Home > Analytics > PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH
Intrinsic Value | Fundamental Analysis

BOM : 500126     NSE : PGHL    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
May 18,2024
Price(EOD): ₹ 4,815.05
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 7,992.98 Cr
Value of ₹ 1 Lac invested in PROCTER & GAMBLE HEALTH
on May 20,2019 (price: ₹ 4,537.30)

₹ 1 L

₹ 1.06 L

1W : 1.4% 1M : 2.6% 1Y : -0.7%
COMMUNITY POLL
for PROCTER & GAMBLE HEALTH
Please provide your vote to see the results
PROCTER & GAMBLE HEALTH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Industry Peers & Returns1W1M1Y
PROCTER & GAMBLE HEALTH 1.4% 2.6% -0.7%
SUN PHARMACEUTICAL INDUSTRIES -0.9% 0.9% 62.6%
CIPLA 3.5% 4.2% 51.8%
DR REDDYS LABORATORIES -1% -2.4% 28.4%
ZYDUS LIFESCIENCES 12.2% 18% 103.8%
DIVIS LABORATORIES 0.8% 5.6% 19.3%
MANKIND PHARMA -6.1% -11.9% 54.1%
TORRENT PHARMACEUTICALS 2.9% 6.2% 66.2%
LUPIN 1.5% 4.2% 109.2%

FUNDAMENTAL ANALYSIS OF PROCTER & GAMBLE HEALTH

 
Fundamentals Score
[ Q(TTM): Mar2024, Y: Jun2023
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 PGHL is one of the top 35% companies with good fundamentals ! Discover More →

VALUATION OF PROCTER & GAMBLE HEALTH

 
Valuation Score
[As on : May 18,2024 ]

Ratio Standalone
P/E
P/B
P/S
37.35
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 214.02 Cr
[Latest Qtr - Mar2024 - Standalone Results ]

10.76
P/B Calculated based on Book Value of Rs 743.05 Cr
[Latest Year - Jun2023 - Standalone Results ]

6.84
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Mar2024 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 12% undervalued companies ! Discover More →

FAIR VALUE OF PROCTER & GAMBLE HEALTH

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
26%
38%
23%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF PROCTER & GAMBLE HEALTH



PROCTER & GAMBLE HEALTH vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF PROCTER & GAMBLE HEALTH

Year Debt/Equity ratio
Standalone Consolidated
2023
2022
2021
Avg_3yrs
0
0
0
-
-
-
-
-
[Last Annual Data : Jun2023]
Financial Ratios →

PLEDGED PROMOTER SHARES OF PROCTER & GAMBLE HEALTH

Pledged Promoter Shares
0 %
As on : Dec2023

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF PROCTER & GAMBLE HEALTH

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-18.55%
-33.65%
-37.1%
-35.4%
-21.33%
-15.34%
-20.13%
-21.34%
QtrlyTrend
-8
Latest Qtr: Mar2024
Quarterly Result Analysis →


PROCTER & GAMBLE HEALTH related INDICES

BSE Indices1W1M1Y
S&P BSE SMALL CAP 5.9% 5.6% 61.1%
S&P BSE 250 SMALLCAP 5.7% 4.7% 58.4%
S&P BSE MIDSMALLCAP 5.2% 6.2% 62.2%
S&P BSE 400 MIDSMALLCAP 5.1% 6% 57.9%
S&P BSE ALLCAP 3.2% 3.6% 36.9%
No NSE index found

You may also like the below Video Courses


FAQ about PROCTER & GAMBLE HEALTH


Is PROCTER & GAMBLE HEALTH good for long term investment?

As on May 18,2024, the Fundamentals of PROCTER & GAMBLE HEALTH look Strong and hence it may be good for long term investment! See Financial Performance of PROCTER & GAMBLE HEALTH . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is PROCTER & GAMBLE HEALTH UnderValued or OverValued?

As on May 18,2024, PROCTER & GAMBLE HEALTH is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of PROCTER & GAMBLE HEALTH ?

As on May 18,2024, the Intrinsic Value of PROCTER & GAMBLE HEALTH is Rs. 3,834.88 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 3,834.88
Fair Value [Median EV / Sales Model] : Rs. 3,482.13
Fair Value [Median Price / Sales Model] : Rs. 3,915.36
Estimated Median Fair Value of PROCTER & GAMBLE HEALTH : Rs. 3,834.88

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is PROCTER & GAMBLE HEALTH trading at a Premium or Discount?

As on May 18,2024, PROCTER & GAMBLE HEALTH is trading at a Premium of 26% based on the estimates of Median Intrinsic Value!